Epigenetic Liver Damage: Study Reveals Clues Implicating 1,3-Butadiene by Weinhold, Bob
A 218  v o l u m e  119 | n u m b e r  5 | May 2011  •  Environmental Health Perspectives
News | Science Selections
©
 
R
a
f
i
q
u
a
r
 
R
a
h
m
a
n
/
R
e
u
t
e
r
s
Epigenetic Liver Damage
Study Reveals Clues Implicating 1,3-Butadiene
The petroleum-derived substance 1,3-butadiene is a known human 
carcinogen that is a significant contributor to cancer risk in the United 
States. There is evidence it causes liver, heart, lung, and hematopoi-
etic cancers in rodents through genetic damage. But some researchers 
suspect it also may induce changes through other pathways, includ-
ing epigenetic alterations, which occur when the function of a gene is 
altered while its DNA sequence remains stable. A new study provides 
further evidence 1,3-butadiene may indeed cause epigenetic damage 
[EHP 119(5):635–640; Koturbash et al.]. 
The authors exposed male C57BL/6J mice to inhaled 1,3-butadiene at 
two doses, 6.25 ppm and 625 ppm, for 2 weeks (6 hours per day, 5 days 
per week). The low dose is about 10–100 times higher than typical occupa-
tional and ambient exposures, respectively, while the inhalation pathway is 
considered the most common for human exposure. In the 5 mice exposed 
at each dose, the researchers found numerous dose-dependent alterations 
in genes linked with liver function. Compared with controls, mice in the 
low-dose group had 1 gene with a more than 2-fold increase in expression 
and 5 with a more than 2-fold decrease in expression. Mice in the high-
dose group had 4 genes with a more than 2-fold increase in expression and 
13 with a more than 2-fold decrease in expression. The high-dose mice 
also had a small but significant decrease in body weight.
The authors also found evidence of epigenetic changes that were 
consistent with altered gene expression in the liver. Changes in the 
attachment of methyl groups to DNA are a useful marker of epigenetic 
changes, and the researchers observed significant decreases in 5 markers 
of methylation in the high-dose group and smaller decreases in 4 of the 
5 markers in the low-dose group. High-dose mice also had a roughly 
50% decrease in another methylation indicator.
Changes in histones, proteins that help regulate gene expression, also 
occurred in the high-dose mice, with significant decreases in methyla-
tion based on 3 biomarkers. Expression of proteins involved in DNA 
methylation and histone methylation decreased while expression of a 
protein involved in histone demethylation increased, consistent with the 
observed decreases in DNA and histone methylation.
These findings fit with earlier research into epigenetic effects of 
other substances and are consistent with other mechanistic evidence 
of how such damage can play a role in the onset of various adverse 
health effects, the authors say. If additional studies—including studies 
of female mice, other mouse strains, and other animals—repeat these 
findings, this would indicate multiple modes of carcinogenicity for 
1,3-butadiene and could lead to establishment of specific biomarkers 
for epigenetic damage that could be used in future toxicity and expo-
sure assessments.
Bob Weinhold, MA, has covered environmental health issues for numerous outlets since 1996. He 
is a member of the Society of Environmental Journalists.
Arsenic and 
Infectious 
Disease
A Potential Factor 
in Morbidity among 
Bangladeshi Children
Lower respiratory tract infection (LRTI) 
and diarrhea are two of the most com-
mon causes of morbidity and mortality 
in children under 5 years old, espe-
cially in low-income countries. A new 
prospective cohort study of the link 
between these types of infections and 
arsenic exposure revealed a dose-depen-
dent increase in LRTI and diarrhea in 
relation to maternal arsenic exposure 
[EHP 119(5):719–724; Rahman et al.].
Earlier studies linked prenatal arse-
nic exposure to increased risk of infant 
mortality, and infectious disease has been 
suggested as a potential underlying cause 
in these deaths. No epidemiologic studies 
have been conducted to support that 
explanation, but there is evidence from 
a few animal and human studies that 
arsenic may cause immunosuppression. 
The  current  study  included 
1,552 live-born infants of women enrolled during 2002–2004 in Matlab, 
Bangladesh. Arsenic exposure was assessed by measuring inorganic arsenic 
in maternal urine samples collected at gestational weeks 8 and 30. After 
birth, information on symptoms of LRTI and diarrhea in infants was 
collected at monthly home visits in which mothers recalled symptoms 
that had occurred over the previous 7 days.
The estimated relative risk of LRTI 
and severe LRTI increased by 69% and 
54%, respectively, in the participants 
whose  mothers  had  urinary  arsenic 
concentrations in the highest quintile 
(262–977 μg/L), compared with offspring 
of mothers whose exposure was in the 
lowest quintile (less than 39 μg/L). The 
relative risk of diarrhea increased 20% 
for the highest-exposure group compared 
with the lowest-exposure group.
The authors observed that relative 
risks of LRTI and diarrhea increased 
irrespective of sociodemographic fac-
tors or nutritional status of the women. 
However, further evaluation is needed in 
a larger sample to evaluate possible effect 
modification, because the risks appeared 
more pronounced in low social strata.
Strengths of the study include the 
large sample size, the objective measure 
of arsenic exposure, and the followup of 
infants for one full year, which the authors 
say would reduce any influence of seasons 
on infection rates. Potential limitations 
include lack of measurements of infant 
exposure to arsenic, a lack of information 
about other potentially toxic substances in 
water and food, and reliance on mothers’ 
reports of disease symptoms and signs. 
Given the millions of people worldwide 
who drink well water with elevated arsenic concentrations, the study results 
could have serious public health implications and, taken together with 
previous studies showing health effects from this exposure, emphasize the 
need to reduce arsenic exposure via drinking water.
Angela Spivey writes from North Carolina about science, medicine, and higher education. She 
has written for EHP since 2001 and is a member of the National Association of Science Writers.
More than 50 million people in Bangladesh 
are believed to be chronically exposed to 
drinking water with arsenic concentrations 
exceeding the WHO standard of 10 µg/L. Passing Down Pollution
Calculating Intergenerational Exposure to PCBs
Countries around the world began phasing out production of polychlo-
rinated biphenyls (PCBs) in the 1970s after adverse health and environ-
mental effects of these chemicals came to light. A new study calculating 
intergenerational differences in human PCB exposure now suggests 
some of the highest exposures occurred well after the chemicals were 
phased out [EHP 119(5):641–646; Quinn et al.].
PCBs are manufactured organic chemicals that were used in numer-
ous industrial applications starting in the 1920s. Although they have been 
phased out of production, PCBs are still being released into the environ-
ment from preexisting applications and improper disposal of products 
that contain them. Because of their chemical stability and transportability 
they bioaccumulate in the food chain, readily enter the human food sup-
ply, and pass from mother to infant in utero and during breastfeeding, 
with potentially harmful effects on the endocrine, immune, nervous, and 
reproductive systems.
In 2010 three authors of the current study and another colleague 
developed and tested a mechanistic model called CoZMoMAN that 
accounts for PCBs’ emissions history and movement through the envi-
ronment, the food chain, and the human body to predict concentrations 
in a population’s body fat. For the present study, the authors used 
CoZMoMAN to calculate how PCB concentrations in fat changed over 
the lifetimes of hypothetical Swedish women born each decade between 
1920 and 2010. They also analyzed how such factors as the age at which 
a woman first gives birth, the number of children she bears (parity), and 
whether she breastfeeds her babies affect both her PCB body burden and 
that of her children.
The model predicted that a woman’s PCB exposure was determined 
primarily by when she was born. Women born in the 1960s were 
predicted to have the highest cumulative lifetime exposure—PCBs were 
already in widespread use when these women were born, and emissions 
peaked as they were maturing in the 1970s. However, it was women 
born in the 1980s who experienced the highest prenatal exposure and the 
highest peak concentration at any given age. Prenatal exposure to PCBs 
can be associated with serious neurologic and reproductive consequences.
Prenatal exposure was strongly influenced by children’s birth order, 
whereas postnatal exposure was influenced by whether children were fed 
breast milk or infant formula. A mother’s reproductive characteristics—
specifically breastfeeding and parity—had a greater impact on her 
children’s PCB burden than on her own, but these characteristics only 
appeared to matter for infants born after the PCB phaseout. Because 
both pre- and postnatal PCB exposures have been associated with health 
complications, the results suggest the health effects of PCBs are likely to 
persist over several more generations.
Rebecca Kessler, based in Providence, RI, writes about science and the environment for various 
publications. She is a member of the National Association of Science Writers and the Society of 
Environmental Journalists.
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Window for Dioxin Damage
Sperm Quality in Men Born after the Seveso Disaster
Animal studies demonstrate that endocrine-disrupting chemicals 
such as dioxin and dioxin-like compounds are particularly damaging 
when exposure occurs during prenatal and early-life development. A 
new study links dioxin exposure within this time frame in humans 
to reduced sperm quality in adult males [EHP 119(5):713–716, 
Mocarelli et al.].
In July 1976, a trichlorophenol plant explosion near Seveso, Italy, 
resulted in dioxin contamination of the surrounding area. Thirty-nine 
men who were born near Seveso between March 1977 and January 1984 
made up the exposed group in the current study, while 58 age-matched 
controls were born outside the contaminated area. Archived blood serum 
samples collected from the exposed men’s mothers in 1976–1977 were 
used to estimate the men’s prenatal dioxin exposure. 
All the men completed a health and lifestyle question-
naire and provided blood and semen samples. Blood 
samples were used for health screening tests, dioxin 
measurements, and hormone assays, and semen samples 
were analyzed for sperm motility, concentration, and 
morphology. 
Exposed mothers had an estimated median serum 
dioxin concentration of 26.0 ppt at conception, whereas 
the median for the comparison group was estimated 
at 10.0 ppt. Twenty-one of the 39 exposed men were 
breastfed, which increased their median estimated total 
dioxin exposure to 40 ppt at 4–5 months of age, a 
critical time point for proliferation of Sertoli cells, which 
determine spermatogenic potential in adulthood.
Breastfed exposed men had significantly decreased 
sperm concentration, total sperm count, and total num-
ber of motile sperm in contrast to the 58 men in the 
comparison group. Compared with both the 36 breast-
fed comparison men and the 18 formula-fed exposed 
men, the 21 breastfed exposed men also had increased 
follicle-stimulating hormone and decreased inhibin B, a hormone pattern 
previously shown to be a marker for impaired spermatogenesis.
This is the first human study to show that dioxin exposure during 
development may permanently impair sperm production in adulthood. 
Current serum dioxin concentrations in the U.S. and European gen-
eral populations of infants are far below levels that would trigger adverse 
effects. However, the study results may explain widespread low sperm 
counts in young men exposed during breastfeeding during times when 
background dioxin concentrations were 10–20 times higher than today. 
They also raise concerns for areas that are currently undergoing rapid 
industrial development and potential related contamination with dioxin 
and other endocrine-disrupting chemicals.
Julia R. Barrett, MS, ELS, a Madison, WI–based science writer and editor, has written for 
EHP since 1996. She is a member of the National Association of Science Writers and the Board of 
Editors in the Life Sciences.
The 10 July 1976 Seveso disaster 
resulted in the highest dioxin exposure 
documented in humans and the largest 
cohort of dioxin-exposed women.